AZAD's complete network comprising a sales and marketing force, Swiss R&D facilities, and international production partners ensures cutting edge service in the development and supply of quality generic APIs and selected Finished Dosage Forms.


Quality Management by PharmaConsult

Management of Azad quality policies, procedures, programmes and practices to assure company continuous improvement, conformance and effectiveness.


Partners - generic APIs


The company was founded in Schaffhausen in 1936 and joined The Johnson & Johnson Family of Companies in 1959. The J & J Family of Companies, with approx­imately 120'000 employees, is the world's most comprehensive and broadly based manu­facturer of health care products, as well as a provider of related services, for the consumer, pharmaceutical and professional markets. Johnson & Johnson Family of Companies has 250 operating com­panies in 57 countries around the world, selling products in more than 175 countries.


YONSUNG Fine Chemicals Co. was founded in 2000. The company is a top quality, fast growing manufacturer of APIs, especially, PROSTAGLANDINS and related products for pharmaceutical applications.


Neuland is a leading Hyderabad based manufacturer of active pharmaceutical ingredients and an end-to-end solution provider for the pharmaceutical industry for chemistry related ser­vices. They are more than 1000 employees strong and their core competence lies in the ap­plication of strong process chemistry to manufacturing in regulatory environment.


Chunghwa Chemical Synthesis & Biotech Co. Ltd. (CCSB) founded in 1964, is one of the largest API manufacturer in Taiwan, located in the suburb of Taipei. CCSB has developed more than 30 bulk pharmaceutical products.


Farmak's tradition of industrial chemical production began in 1934 and has been developed in the years since. Nowadays Farmak, a.s. (joint stock company) is a private, independent Czech company.


Polpharma is the largest manufacturer of drugs and active pharmaceutical ingredients in Pol­and. Polpharma's products are exported to over 50 countries of the world.


NerPharMa is a newly established company, operating since January 2010. Together with its sister company NerPharMa DS (dealing with manufacturing of API), it was created as a spin-off from Nerviano Medical Sciences, the largest, privately owned R&D facility in Italy.


Beijing Cavir Bio-Pharm Co.,Ltd. is a high-tech enterprise located in Beijing with a R&D staff of 90 people. The company is focused on pharmaceutical R & D and APIs manufacture.


Contract manufacturers – Drug Products


HELP S.A. is a Pharmaceutical Company, established in 1971, engaged in the Research, Development, Manufacturing, Distribution and Commercialisation of high quality, prescription drug products. Their foundation and future growth lies in the development & manufacturing of generic products. Their manufacturing plant is located in the North of Greece.


The Farmigea Istituto Chimico Farmaceutico Sperimentale was established in 1946 and began manufacturing. In the beginning the firm produced a wide range of generic products like health tonics in syrup form, extracts, dermatological creams, ointments and even its first eye-drops. Farmigea's International Business Development Department has two main objectives: to increase export sales of its proprietary medicines and to enhance the international aware-ness of our proprietary medicines through a network of strategic alliances. Today Farmigea is present in over twenty countries throughout the world.


The Company's roots stretch back to the Lisbon of 1949 and the founding of "Laboratório Medicamenta". In 1988, Medicamenta was bought by the Johnson & Johnson Company Cilag and in 1995, the Belgian company Janssen merged with Cilag leading to "Janssen-Cilag Pharmaceutical": Believing in the potential of the Portuguese pharmaceutical industry, new cutting edge facilities were built in Queluz. In 2004, a group of Portuguese business entrepreneurs took over the Janssen-Cilag and the company name Lusomedicamenta Sociedade Técnica Farmacêutica S.A appeared. They have been acquired as CDMO by the Swedish Group Recipharm in 2014, although the company name Lusomedicamenta remained.


Established in 1978 in Korea, Taejoon is one of the leading ophthalmics and contrast media companies in Korea. It is EU GMP certified and has a state of the art manufacturing including blow fill and seal technology.


Founded in 1980 in Vienenburg Germany the company produces thymus extracts and various organ extracts and manufactures liquid and freeze-dried parenterals.

Thymoorgan has been acquired by HIKMA Pharma Group in 2007 and operates as a subsidiary of Hikma Pharmaceuticals to expand into the generic injectable oncology market.